Beginning August 15, the nasal-spray flu vaccine Flumist is available in 34 states for at-home administration for people aged 2 to 49 years old. News coverage and online conversations about the vaccine focused on access, emphasizing that vaccination rates were down last flu season, especially among children and older adults. Some posts expressed excitement about trying the vaccine, but also concern about correct administration and insurance coverage. Vaccine opponents criticized the news, claiming that “Big Pharma” is trying to kill people at home and that all flu vaccines are a “scam.” Others claimed that the vaccine would make more people sick and recommended unproven “natural” flu remedies.
Recommendation
Messaging may explain that FluMist has been in use for over 20 years. Like the flu shot, it is safe and reduces the risk of infection, serious illness, complications, and death. Health communicators may emphasize that the vaccine is approved for people aged 2 to 49 years, and is generally not recommended for people who are pregnant or have weakened immune systems.
Fact-checking sources: Everyday Health, CBS News
